Resmed (RMD) revenue: $5.7B
Resmed reported $5.7B of revenue for the year ended Jun 30, 2026, up 9.9% from $5.1B a year earlier.
From Resmed's filings with the SEC · Read the filing · RMD stock page
Resmed revenue by year
#643 of 3,622 US companies by revenue · See the full ranking
| Year ended | Revenue | Change |
|---|---|---|
| Jun 30, 2026 | $5.7B | +10% |
| Jun 30, 2025 | $5.1B | +10% |
| Jun 30, 2024 | $4.7B | +11% |
| Jun 30, 2023 | $4.2B | +18% |
| Jun 30, 2022 | $3.6B | +12% |
| Jun 30, 2021 | $3.2B | – |
Revenue of similar companies
Companies in the same industry as Resmed, by SEC industry code, with the closest revenue. Each name opens the same page for that company.
| Company | Revenue, latest year | Year ended |
|---|---|---|
| Baxter International | $11.2B | Dec 31, 2025 |
| Solventum | $8.3B | Dec 31, 2025 |
| Resmed | $5.7B | Jun 30, 2026 |
| Dexcom | $4.7B | Dec 31, 2025 |
| MiniMed Group | $3.1B | Apr 24, 2026 |
| West Pharmaceutical Services | $3.1B | Dec 31, 2025 |
| Globus Medical | $2.9B | Dec 31, 2025 |
Questions and answers
What is Resmed's revenue?
Resmed reported $5.7B of revenue for the year ended Jun 30, 2026, up 9.9% from $5.1B a year earlier.
Numbers as reported in Resmed's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology